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Abstract
Chemical information is now seen as critical for most areas
    of life sciences. But unlike Bioinformatics, where data is
    Openly available and freely re−usable, most chemical
    information is closed and cannot be re−distributed without
    permission. This has led to a failure to adopt modern
    informatics and software techniques and therefore paucity of
    chemistry in bioinformatics. New technology, however, offers
    the hope of making chemical data (compounds and properties)
    Free during the authoring process. We argue that the technology
    is already available; we require a collective agreement to
    enhance publication protocols.
B O D Y
Background
In "Representation and Use of Chemistry in the Global
    Electronic Age"[1] we showed that new technology can
    provide great increases in the quantity and quality of
    aggregated chemical information published in the primary
    literature. We also argued the benefits of Open Access and Open
    Data. The current invited overview and a parallel technical
    article extends the same methodology to chemistry in
    bioinformatics to remove the loss and corruption of data that
    occurs in current publishing. We are pleased that this is an
    Open Access publication, and we expect that bioinformatics,
    with its culture of Open Data, is more likely than mainstream
    chemistry to adopt new approaches. Benefits include higher
    quality, greater availability, and development of the
    Biochemical Semantic Web where robots mine text and data as a
    basis for knowledge−driven science. We argue that funders,
    institutions, authors, editors, publishers and readers will all
    benefit  
Biosciences now require large amounts of detailed chemical
    information, examples of which include the  occurrence and
    role of small−molecules in biological processes; the mechanism
    of biochemical reactions and interactions; the structure and
    properties of biomolecules; reagents, protocols and
    classificatory tools for performing bioscience; chemistry in
    the ecosphere. Such information is only available in a
    dispersed manner in the primary literature and current
    mechanisms for its collection and dissemination do not meet the
    needs of bioscience. However if there is a communal will,
    modern chemical informatics technology can provide what is
    required. The excellent model for the capture of macromolecular
    sequence and structure data inform our architecture.
    Published data include mention of chemical compounds (often
    in free text), details of their synthesis (in vivo and in
    vitro), proof of their structure (spectra and analytical data),
    methods and reagents in bioscience protocols, the physical and
    biological properties and reaction of compounds both in enzymes
    and enzyme−free systems. With the tools that we and others have
    developed, this information can now be automatically
    captured with high precision from primary publications,
    especially if structured authoring tools are widely used.
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    Unlike bioscientists who develop data− and text−mining
    tools, conventional chemists appear culturally more suspicious
    of robotic data extraction and continue to rely on manually
    curated secondary publications whose philosophy has barely
    altered over 120 years. Such sources are necessarily incomplete
    in time, coverage and coverage of information types. For
    example for 99+% of all newly synthesised compounds the papers
    report that Infra−red spectra have been recorded, but at most
    1% of this is available in electronic form. We argue that even
    modest improvement in such a data capture rate would make an
    enormous difference. Moreover the data would be of consistently
    higher quality than The main challenge is cultural. Biosciences
    and crystallography have communally convinced authors and
    publishers of the value of author−based deposition of data,
    later aggregated in communally accessible databanks. This
    largely does not currently happen in chemistry, where
    information is manually extracted from the primarily
    literature, jealously guarded and sold back to the community.
    Mechanisms such as "supporting or supplemental data deposition"
    are not widely used, and when they are, little care is given to
    enabling its re−use. Regrettably one of the major secondary
    publishers has recently criticised the bioscience community for
    aggregating chemical data:
 "It [PubChem] would not only injure us significantly, it
      would put information for free in the hands of world
      scientists and do it all with taxpayer money," Massie [CEO,
      CAS] said. "For me to wake up one morning and find I have to
      compete with my own government is extraordinary."[2]
The attitude in chemistry to modern informatics (XML,
    ontologies, RDF, text−mining, metadata, etc.)[3] is
    largely apathetic, with some data− or software−centric
    organisations actively opposing interoperability for commercial
    reasons. This problem extends to mainstream chemical software,
    where there are no Open standards and where algorithms are
    closed and obscure. We have argued that the large data
    aggregators produce vendor−centric access systems to meet their
    needs rather than the community’s. Another problem is that
    access is often only allowable on a per−item basis rather than
    to the data collection as a whole. This monopolistic "thought
    control" in chemistry stifles innovation in data−led science.
    However the Opens (Data, Source, Access, Standards) are changing
    the practice of scientific informatics and chemistry is
    starting to be affected.
    We therefore look to bioscience to take a lead in helping
    realise the following vision. We now believe that there are
    already enough Open tools and Open resources which can make the
    vision attractive and cost−effective.
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Results
 
A model for automatic capture of chemical information
    Much chemical data is largely context−free in that it can be
    understood and recreated independently of the location or
    motivation. The primary data model, inspired by Konrad
    Beilstein in the 19th century, has three components: compound,
    properties and citations. A pure compound is described by an
    immutable structural formula and has precisely reproducible
    properties. Current thinking asserts that the biological action
    of a compound is, in principle, reproducible and predictable if
    the system is carefully enough replicated and the components
    understood. This is the central dogma of the chemically−based
    pharmaceutical industry and the chemical information industry
    on which it relies.
    Chemistry has a tradition of ensuring quality through
    reporting properties and analysis, so every new compound (and
    many re−synthesised ones) must have published measurements of
    properties to justify their identity and purity. These facts
    are available, in text form, in the primary literature in which
    over a million new compounds are published annually. Because
    structure predicts properties, and because drug discovery is so
    difficult, the pharmaceutical industry tests many compounds for
    biological activity. The data in these public publications is a
    major feedstock for the chemical information industry.
   The chemical bioscientist has almost all of the required
    information available in electronic form on their benchtop
    already! It could be deposited for the scientific community
    with virtually no human intervention. We believe that, with the
    help of forward looking publishers, a working protocol can be
    set up in bioscience, which will then inspire (or terrify)
    mainstream chemical informatics. Note that much of the
    information captured is additional to that which the current
    abstracters collect.
    We argue that the key components to automatically capture
    chemical information are already in place (and are discussed in
    more detail in an accompanying technical article). We envisage
    the chemistry which can be captured using such mechanisms
    includes (a) Chemical entities and names. Many compounds have
    no explicit structures and are mentioned only by name or
    identifiers. Where these relate to specific compounds it is
    valuable to link them to a precise identification, such as
    PubChem. (b) Molecular structure, expressed as a compositional
    formula (e.g. CH3OH for methanol) and a graphical
    structural formula ("2D diagram" or connection table). (c)
    Spectra and physical properties. Much such information is
    already in digital form when produced by instruments (whose
    manufacturers are starting to create Open approaches[4],
    but is largely destroyed by conventional publishing processes.
    If a community−wide digital template for the submission of this
    information were available and encouraged by publishers it
    would be welcomed by many, would eliminate errors introduced by
    transcription, and enable machine−reviewing of data leading to
    a higher standard of published data.
    The basis of our model involves conversion of experimental
    data to XML and its merger with the conventional text (giving a
    "datument"[5]). The author uses a authoring tool which
    can manage structured XML documents and provide normal textual
    support (spellchecks, etc.). The resulting datument contains
    fine−grained markup of facts (molecules, measurements,
    properties, chemical names) and can automatically be used to
    create derivatives such as the "full−text" or the "supplemental
    data". The complete datument, if Open, or the "data" if not is
    then reposited for further harvesting. All compound/property
    data is available for datamining and computational re−use (e.g.
    for further in silico prediction.
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    Realising the vision
    Data repositing and Maintenance
    The current dissemination of data through publishers is
    largely unsatisfactory. Some, such as the International Union
    of Crystallography, are committed; others in the biosciences
    see the value of semantically enhanced data. Many publishers
    allow the deposition of factual "supplementary data" but our
    experience with most is that it is an unwelcome chore, poorly
    resourced and maintained. Moreover although reviewers are often
    do what they can to validate data, publishers themselves do
    not. We believe that many publishers would welcome a model
    where they were no longer involved in data repositing. The
    crystallographic experience has shown that expert computer
    programs can act as powerful reviewers complementing the human;
    automatic curation enhances, rather than lowers, data
    quality.
    Our model is based on the availability of repositories,
    primarily Institutional, that accept data as well as full text.
    Already some academic institutions and an increasing number of
    funders mandate that research output should be reposited and
    there are national initiatives to develop the infrastructure.
    The storage for XML−ised chemical data is modest (less than 1
    mbyte per publication) and we have shown that large numbers of
    molecules can be deposited in our own institutional repository[6]
    and recovered by undirected search engines such as Google.[7]
    Chemical data has required no semantic maintenance (e.g.
    through changes in meaning or use) over many decades and we see
    this continuing, so that the maintenance costs are those
    general to any repository.
    
Components in a repository have a unique handle with which,
    in principle, a Digital object or other identifier (DOI)[8] can
    be associated so that data can be cloned for access and
    preservation. The handle or DOI would be published in the "full
    text" and would bind the data to it more effectively that at
    present and hopefully indefinitely.
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    Metadata
Through InChI[8]  and a controlled vocabulary of
    chemical properties, generic search engines can achieve a very
    high degree of recall. The means that discovery and aggregation
    are built on maintenance−free generic technology and can be
    made completely automatic, Conventionalists will argue that
    human curation is essential for re−usable chemical data. In
    similar vein to much bioinformatics we argue that robots can
    discover patterns in data, compounds and authors which are at
    least as powerful as many current abstracting services. Where
    human evaluation is critical (e.g. in human medicine, patents,
    etc.) then the robots will provide the primary resources on
    which a judgement can be based.
    Rights
We assume that most bioscience authors and publishers will
    agree that whether or not a paper is Open Access the facts (and
    thereby all "supplemental data") therein are not copyrightable.
    XML resolves differences of interpretation in that all XML
    markup is regarded as identifying factual information and
    consistent with re−use under (say) the Budapest Open Access
    Initiative. In this way all published chemical data can be made
    immediately, completely and clearly available for indefinite
    scientific re−use.
    Potential
Because the chemical information is structured we now have a
    biocheminformatics "cycle" where, for the first time, large
    scale robotic data analysis can take place. The data in the
    research (laboratory, in silico, or both) are published
    in a lossless manner. Molecules and their properties have
    unique identifiers as described above and can be integrated
    into mainstream bioinformatics in the same manner as
    collections such as PubChem, MSD (at EBI), KEGG, etc. They will
    bring the added value of consistently captured property data
    and spectra. We also expect that many  in silico
    properties will then be systematically added.
   Author and publisher compliance
    The introduction of structured authoring tools (e.g.
    Publicon)[9] will help this process considerably.
    Templates can be created for the chemical components described
    above and where the information exists in XML (connection
    tables, spectra, properties) it should be as easy as for
    committed authors as using a semantically void tool (e.g.
    Word). Where information needs to be converted from legacy
    formats we have created Open Web Services which publishers (and
    authors) may clone and customise. We expect authors to have a
    greater incentive (even if only through mandation) to reposit
    data and to disseminate research findings. This also raises the
    vision of changing the "citation economy" (which values market
    perception) to a "reuse economy" where a the data in a paper
    are valued by how often they are re−used.
B A C K M A T T E R
5
References
1. Murray−Rust P, Rzepa HS, Tyrell SM, Zhang Y: Org. Biomol. Chem., 2004, 2:3192|3203.
2. Heller S. Posted to CHMINF−L,   quoting the Columbus Despatch. PubChem: the NIH/NCBI collection of small 
molecules and properties. CAS: Chemical Abstracts, a Division of the American Chemical Society. 
https://listserv.indiana.edu/cgi−bin/wa−iub.exe?A2=ind0504&amp;L=CHMINF−L&amp;D=0&amp;H=0&amp;I=−3&amp;
O=T&amp;T=0&amp;P=20446 
3. For information on this infrastructure, see URL http://www.w3c.org/ 
4. For information, see URL http://animl.sourceforge.net/ 
5. Murray−Rust P, Rzepa HS: The Next Big Thing: From Hypermedia to Datuments. J. Digital Inf., 2004, 5.
6. For an example of  institution making all its research public, see  
http://www.jisc.ac.uk/index.cfm?name=free_access_to_university_research_news171204 
7. Coles SJ, Day NE, Murray−Rust P, Rzepa HS, Zhang Y: Enhancement of the Chemical Semantic Web through 
the use of  InChI Identifiers. Org. Biomol. Chem., 2005, 3:1832|1834.
8. Murray−Rust P, Rzepa HS, Stein S: The InChI as an LSID for molecules in lifescience. W3C Workshop on 
Semantic Web for Life Sciences, 27−28 October 2004, Cambridge,  Massachusetts USA., 2004. 
http://lists.w3.org/Archives/Public/public−swls−ws/2004Sep/att−0026/inchi.html 
9. For further information, see  URL. http://www.biomedcentral.com/info/ifora/publicon/ 
6
